Bao Pharma-B Added to MSCI Global Small Cap Index, Reflecting Global Recognition of Its Innovative R&D Strength

Stock News09:58

On May 14, 2026, Bao Pharma-B (02659) announced that, according to the MSCI index review results published on May 12, 2026, the company has been successfully included as a constituent of the MSCI Global Small Cap Indexes. The relevant adjustment will officially take effect after the market close on May 29, 2026. The MSCI Global Small Cap Indexes are compiled by MSCI Inc. and are designed to measure the performance of representative and investable small- and mid-cap companies across global markets. The MSCI index system is one of the most influential index systems globally, tracked by over $17 trillion in global institutional investor assets, encompassing various professional investment institutions such as sovereign wealth funds, pension funds, mutual funds, and exchange-traded funds (ETFs). Its selection criteria include core metrics like market capitalization, liquidity, industry representation, and corporate governance. Inclusion in this index signifies a further enhancement of Bao Pharma-B's visibility and influence in the global capital markets. It is expected to help attract broader attention from international investors, potentially leading to incremental passive fund allocation, and further improve the stock's market liquidity, trading activity, and international profile.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167865321?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 09:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167865321","market":"fut","top_or_hot":-1,"title":"Bao Pharma-B Added to MSCI Global Small Cap Index, Reflecting Global Recognition of Its Innovative R&D Strength","media":"Stock News","content":"<p>On May 14, 2026, Bao Pharma-B (02659) announced that, according to the MSCI index review results published on May 12, 2026, the company has been successfully included as a constituent of the MSCI Global Small Cap Indexes. The relevant adjustment will officially take effect after the market close on May 29, 2026. The MSCI Global Small Cap Indexes are compiled by MSCI Inc. and are designed to measure the performance of representative and investable small- and mid-cap companies across global markets. The MSCI index system is one of the most influential index systems globally, tracked by over $17 trillion in global institutional investor assets, encompassing various professional investment institutions such as sovereign wealth funds, pension funds, mutual funds, and exchange-traded funds (ETFs). Its selection criteria include core metrics like market capitalization, liquidity, industry representation, and corporate governance. Inclusion in this index signifies a further enhancement of Bao Pharma-B's visibility and influence in the global capital markets. It is expected to help attract broader attention from international investors, potentially leading to incremental passive fund allocation, and further improve the stock's market liquidity, trading activity, and international profile.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bao Pharma-B Added to MSCI Global Small Cap Index, Reflecting Global Recognition of Its Innovative R&D Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBao Pharma-B Added to MSCI Global Small Cap Index, Reflecting Global Recognition of Its Innovative R&D Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-14 09:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On May 14, 2026, Bao Pharma-B (02659) announced that, according to the MSCI index review results published on May 12, 2026, the company has been successfully included as a constituent of the MSCI Global Small Cap Indexes. The relevant adjustment will officially take effect after the market close on May 29, 2026. The MSCI Global Small Cap Indexes are compiled by MSCI Inc. and are designed to measure the performance of representative and investable small- and mid-cap companies across global markets. The MSCI index system is one of the most influential index systems globally, tracked by over $17 trillion in global institutional investor assets, encompassing various professional investment institutions such as sovereign wealth funds, pension funds, mutual funds, and exchange-traded funds (ETFs). Its selection criteria include core metrics like market capitalization, liquidity, industry representation, and corporate governance. Inclusion in this index signifies a further enhancement of Bao Pharma-B's visibility and influence in the global capital markets. It is expected to help attract broader attention from international investors, potentially leading to incremental passive fund allocation, and further improve the stock's market liquidity, trading activity, and international profile.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1167865321","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167865321","pubTimestamp":1778723901,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"On May 14, 2026, Bao Pharma-B (02659) announced that, according to the MSCI index review results published on May 12, 2026, the company has been successfully included as a constituent of the MSCI...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","02659":"宝济药业-B","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK4585":"ETF&股票定投概念","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","MSCI":"MSCI Inc","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","BK4588":"碎股","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4112":"金融交易所和数据","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC"},"translate_title":"宝药业-B加入MSCI全球小型股指数，体现全球对其创新研发实力的认可","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1,"MSCI":1},"content_text":"On May 14, 2026, Bao Pharma-B (02659) announced that, according to the MSCI index review results published on May 12, 2026, the company has been successfully included as a constituent of the MSCI Global Small Cap Indexes. The relevant adjustment will officially take effect after the market close on May 29, 2026. The MSCI Global Small Cap Indexes are compiled by MSCI Inc. and are designed to measure the performance of representative and investable small- and mid-cap companies across global markets. The MSCI index system is one of the most influential index systems globally, tracked by over $17 trillion in global institutional investor assets, encompassing various professional investment institutions such as sovereign wealth funds, pension funds, mutual funds, and exchange-traded funds (ETFs). Its selection criteria include core metrics like market capitalization, liquidity, industry representation, and corporate governance. Inclusion in this index signifies a further enhancement of Bao Pharma-B's visibility and influence in the global capital markets. It is expected to help attract broader attention from international investors, potentially leading to incremental passive fund allocation, and further improve the stock's market liquidity, trading activity, and international profile.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167865321","isCrawlerRequest":true}